May 28 (Reuters) - Europe's medicines regulator on Friday backed the use of Pfizer's COVID-19 vaccine for children as young as 12, paving way for a broader roll-out in the region after similar clearances in the United States and Canada.
The European Medicines Agency's endorsement comes weeks after it began evaluating extending use of the vaccine, developed with Germany's BioNTech , to include 12- to 15-year olds. It is already being used in the European Union for those aged 16 and older.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments